BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7868152)

  • 21. Molecular strategies for clinical xenotransplantation in cardiothoracic surgery.
    Hoopes CW; Platt JF
    Semin Thorac Cardiovasc Surg; 1996 Apr; 8(2):156-74. PubMed ID: 8672569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xenotransplantation: recent progress and current perspectives.
    Platt JL
    Curr Opin Immunol; 1996 Oct; 8(5):721-8. PubMed ID: 8902399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-mediated activation of the classical complement pathway in xenograft rejection.
    Roos A; Daha MR
    Transpl Immunol; 2002 May; 9(2-4):257-70. PubMed ID: 12180840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts.
    Kaplon RJ; Michler RE; Xu H; Kwiatkowski PA; Edwards NM; Platt JL
    Transplantation; 1995 Jan; 59(1):1-6. PubMed ID: 7839407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients.
    Dalmasso AP; Vercellotti GM; Fischel RJ; Bolman RM; Bach FH; Platt JL
    Am J Pathol; 1992 May; 140(5):1157-66. PubMed ID: 1580328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intervention strategies and agents mediating the prevention of xenorejection.
    Ghebremariam YT; Smith SA; Anderson JB; Kahn D; Kotwal GJ
    Ann N Y Acad Sci; 2005 Nov; 1056():123-43. PubMed ID: 16387682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xenotransplantation--state of the art--update 1999.
    Bühler L; Friedman T; Iacomini J; Cooper DK
    Front Biosci; 1999 Apr; 4():D416-32. PubMed ID: 10209058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a pig-to-goat orthotopic lung xenotransplantation model to study beyond hyperacute rejection.
    Macchiarini P; Oriol R; Azimzadeh A; de Montpreville V; Wolf P; Dartevelle P
    J Thorac Cardiovasc Surg; 1999 Nov; 118(5):805-14. PubMed ID: 10534685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors in xenograft rejection.
    Robson SC; Schulte am Esch J; Bach FH
    Ann N Y Acad Sci; 1999 Jun; 875():261-76. PubMed ID: 10415573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.
    Magee JC; Collins BH; Harland RC; Lindman BJ; Bollinger RR; Frank MM; Platt JL
    J Clin Invest; 1995 Nov; 96(5):2404-12. PubMed ID: 7593628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that rat xenoreactive antibodies recognize multiple protein antigens on guinea pig endothelial cells and platelets.
    Scherrer L; Leventhal JR; Matas AJ; Dalmasso AP
    Transplantation; 1994 Aug; 58(4):458-66. PubMed ID: 8073515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection.
    Candinas D; Belliveau S; Koyamada N; Miyatake T; Hechenleitner P; Mark W; Bach FH; Hancock WW
    Transplantation; 1996 Dec; 62(12):1920-7. PubMed ID: 8990388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A murine model of antibody-mediated hyperacute rejection by galactose-alpha(1,3)galactose antibodies in Gal o/o mice.
    McKenzie IF; Li YQ; Patton K; Thall AD; Sandrin MS
    Transplantation; 1998 Sep; 66(6):754-63. PubMed ID: 9771839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic engineering as an approach to xenotransplantation.
    Bach FH
    World J Surg; 1997; 21(9):913-6. PubMed ID: 9361504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolongation of cardiac xenograft survival by depletion of complement.
    Leventhal JR; Dalmasso AP; Cromwell JW; Platt JL; Manivel CJ; Bolman RM; Matas AJ
    Transplantation; 1993 Apr; 55(4):857-65; discussion 865-6. PubMed ID: 8475561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody mediated rejection in pig-to-nonhuman primate xenotransplantation models.
    Cozzi E; Severo M; Bosio E; Besenzon F; Ancona E
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Jun; 5(3):233-53. PubMed ID: 15975037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
    Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
    Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell-endothelial cell interactions in xenotransplantation.
    Dawson JR; Vidal AC; Malyguine AM
    Immunol Res; 2000; 22(2-3):165-76. PubMed ID: 11339353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation.
    Williams JM; Holzknecht ZE; Plummer TB; Lin SS; Brunn GJ; Platt JL
    Transplantation; 2004 Nov; 78(10):1471-8. PubMed ID: 15599311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porcine platelet antigens recognized by human xenoreactive natural antibodies.
    Platt JL; Holzknecht ZE
    Transplantation; 1994 Feb; 57(3):327-35. PubMed ID: 8108867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.